is supergut glp 1 safe The Gut Healthy GLP-1 Booster Packet, 8.1g GLP-1 Daily Support Unflavored Prebiotic
Description
According to the FDA's press release it agreed to approve the drug for obesity based on three randomised, double-blind, placebo-controlled trials during which more than 2,600 patients received Wegovy for up to 68 weeks and more than 1,500 patients received placebo (US FDA 2021)
Ten trials involved individuals with T2D [25,27,30-37], while three focused on obese or overweight subjects without diabetes [26,28,29]
To view or add a comment, sign in I analyzed Eli Lillys #Orforglipron journey the 1st non-peptide oral GLP-1 that could redefine #obesity & T2D care
To clarify, my understanding is that 'Meridia' (Abbott) was voluntarily withdrawn from the market rather than being banned
